ATMI to sell LifeSciences business to Pall Corporation for $185M ATMI, Inc. (ATMI) announced it has reached agreement with Pall Corporation (PLL) to sell ATMI LifeSciences in a transaction valued at $185M. The transaction includes all assets associated with the LifeSciences business, including two locations in Belgium plus a shared facility in Minnesota. ATMI expects the transaction to close during the first quarter of 2014, subject to applicable regulatory approvals and customary closing conditions. After tax cash proceeds from the transaction are expected to be approximately $165M.
News For ATMI;PLL From The Last 14 Days
Check below for free stories on ATMI;PLL the last two weeks.